当前位置: 首页 > 期刊 > 《中国健康月刊》 > 2011年第4期
编号:12291379
透析患者高血压发病机理的研究进展(2)
http://www.100md.com 2011年4月1日 《中国健康月刊》 2011年第4期
     [2]Heerspink HJ, NinomiYa T ,Zoungas S ,et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis:a systematic review and meta-analysis of random:sed Controlled trials. Lancet,2009;373:1009-15

    [3] KhosIa UM,Johnson RJ. Hypenension in lhe hemodlaiysis patient and the“lag phenomenon”: insights into pathophysiology and clinical management.Am J Kidney Dis, 2004;43:739-751

    [4] Agarwal R, Alborzi P, Satyan S,et al. Dry-weight reduction in hypertensive hemodialysis patients(DRIP):a randomized,controlledtrial.Hypertension,2009 ;53(3):500-7

    [5] Nesrallah G, Suri R,Moist L,et al.VoIume control and b1ood pressure management in patients undergoing quotidian hemodialysls.Am J Kidney Dis ,2003;42(suppl 1):13-17

    [6] Chen YC, Lin CJ, Wu CJ,et al. Comparison of extracellular volume and blood pressure in hemodialysis and peritoneal dialysis patients. Nephron Clin Pract,2009;113(2):c112-c116

    [7] De Paula FM,Peixoto AJ,Pinto LV, et alClinical consequences of an individualized sodium prescription in hemodialysis patients KidneyInt ,2004;66:1232-1238

    [8] Sergio FF,Santos M,Aldo JP .Hyertension in dialysis.Curr Opin Nephrol Hypertens,2005,14:111-118

    [9] Foley RN,Herzog CA,Collins AJ.Boold pressure andlong-term mortality in United states hermodialysis patients:USRDS Waves 3 and 4 study.Kidney int 2002 ; 62 : 1784-1790

    作者单位:261041 山东省潍坊市人民医院, 百拇医药(刘亚红 李宏 范兴忠)
上一页1 2